Grants (To Study Anti-Doping Testing in Sports)

Funding Agency:
Partnership for Clean Competition

The PCC has supported world-class research since 2008, spending more than $18.0 M to support novel science around the world. Research and grant-making are the foundation of the PCC and are the focus of everyday business activity. PCC-supported research contributes to a movement in addressing doping’s root causes and ultimately decreasing the use of performance-enhancing drugs by all participants in all sports at all levels of play.

With an emphasis on original work that focuses on improving existing analytical methods for detecting particular drugs, developing new analytical methods to test for substances not currently detectable, and discovering cost-effective approaches for testing widely abused substances across all levels of sport, the following areas of investigation reflect the PCC’s current research priorities:

  • Developing methods of cost-effective testing to detect and deter the use of banned and illegal substances.
  • Developing testing protocols to detect designer substances used for doping purposes.
  • Improving existing analytical methods to detect particular drugs, ex. GH, IGF-1, EPO, hCG.
  • Developing analytical methods to detect performance enhancing drugs not currently detectable.
  • Longitudinal urinary excretion patterns, metabolism and dose-concentration.
  • Critical reviews to support interpretation of laboratory data.
  • Alternative specimens, (ex. oral fluid, dried blood/plasma spots) for testing.

Pre-Applications are reviewed three times per year: March 1, July 1, and November 1. 

Agency Website

Amount Description

There is no maximum amount for PCC funding, though the average funding amount is $225,000. To date, over 80 projects have been funded in over 14 countries world-wide. Approximately 33% of applicants are awarded PCC funding.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

March 1, 2020